Skip to Content
Merck
  • Lack of inhibition of human plasma cholinesterase and red cell acetylcholinesterase by antimony compounds including stibine.

Lack of inhibition of human plasma cholinesterase and red cell acetylcholinesterase by antimony compounds including stibine.

Human & experimental toxicology (1998-05-20)
S A Hussain, D E Jane, P V Taberner
ABSTRACT

1. The toxic gas hypothesis proposes exposure to stibine (antimony trihydride) generated from microbial contamination of cot mattress materials as a possible cause of unexplained death in infancy (SIDS) as a consequence of cholinesterase inhibition. We have measured the direct effects of antimony compounds including stibine on the activity of plasma cholinesterase, red blood cell acetylcholinesterase (AChE) and mouse neuronal AChE in vitro. 2. Colorimetric assays for the different esterases with potassium antimonyl tartrate or antimony trichloride at concentrations up to 10(-3) M in the presence of substrate concentrations sufficient to produce 80% of the maximum reaction rate produced no inhibition of enzyme activity. Exposure of enzyme preparations to stibine gas at concentrations sufficient to cause denaturation of red cell haemogloblin caused no measurable inhibition of esterase activity. 3. We conclude that stibine gas or soluble antimony compounds are not capable of inhibiting cholinesterase activity at toxicologically relevant concentrations.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Antimony(III) chloride, JIS special grade, ≥98.0%
Sigma-Aldrich
Antimony(III) chloride, ≥99.95% trace metals basis
Sigma-Aldrich
Antimony(III) chloride, ACS reagent, ≥99.0%
Sigma-Aldrich
Antimony(III) chloride, ReagentPlus®, 99%
Sigma-Aldrich
Antimony standard solution, 1000 ppm Sb, suitable for atomic absorption spectrometry